Table 1.
Demographic Data
| 0.75% Ropivacaine (n = 38) | 0.375% Ropivacaine (n = 34) | 0.20% Ropivacaine (n = 37) | P value | |
|---|---|---|---|---|
| Age (yrs) | 63.0 (12.0) | 65.5 (17.0) | 59.0 (19.3) | 0.57 |
| Height (cm) | 164.9 (9.6) | 162.8 (13.8) | 161.0 (13.3) | 0.37 |
| Weight (kg) | 62.7 (9.9) | 62.4 (16.9) | 60.6 (16.1) | 0.74 |
| Sex, n (%) | 0.17 | |||
| M | 29 (76.3) | 19 (55.9) | 23 (62.2) | |
| F | 9 (23.7) | 15 (44.1) | 14 (37.8) | |
| ASA PS, n (%) | 0.24 | |||
| I | 6 (15.8) | 9 (26.5) | 12 (32.4) | |
| II | 32 (84.2) | 25 (73.5) | 25 (67.6) | |
| Ephedrine, n (%) | 16 (42.1) | 6 (17.6) | 8 (21.6) | 0.04 |
| Fasting time (min) | 693.8 (178.6) | 762.6 (121.2) | 749.3 (126.9) | 0.09 |
| Mean fluid administration until the end of the study (ml) | 972.6 (99.3) | 987.9 (105.3) | 956.1 (149.9) | 0.54 |
| Type of surgery, n (%) | 0.82 | |||
| Extended cholecystectomy | 4 (10.5) | 3 (8.8) | 8 (21.6) | |
| Hepatectomy | 17 (44.7) | 15 (44.12) | 15 (40.5) | |
| Gastrectomy | 9 (23.7) | 9 (26.5) | 8 (21.6) | |
| Pylorus preserving pancreaticoduodecectomy | 8 (21.1) | 8 (20.6) | 6 (16.2) | |